{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:41:01Z","timestamp":1707939661088},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1007\/s11938-001-0055-x","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:46:02Z","timestamp":1180892762000},"page":"299-308","source":"Crossref","is-referenced-by-count":0,"title":["Diarrhea- and constipation-predominant irritable bowel syndrome"],"prefix":"10.1007","volume":"4","author":[{"given":"Richard","family":"Lea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Whorwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"55_CR1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0016-5085(92)90764-P","volume":"102","author":"NJ Talley","year":"1992","unstructured":"Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ: Dyspepsia and dyspepsia subgroups: a population based study. Gastroenterology 1992, 102:1259\u20131268.","journal-title":"Gastroenterology"},{"key":"55_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.aje.a117548","volume":"142","author":"NJ Talley","year":"1995","unstructured":"Talley NJ, Zinsmeister AR, Melton LJ: Irritable bowel syndrome in a community: subgroups risk factors and health care utilization. Am J Epidemiol 1995, 142:76\u201383.","journal-title":"Am J Epidemiol"},{"key":"55_CR3","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1053\/gast.1997.v112.agast972120","volume":"112","author":"DA Drossman","year":"1997","unstructured":"Drossman DA, Whitehead WE, Camilleri M: Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997, 112:2120\u20132137. A useful review of irritable bowel syndrome in general. Guidelines from the American Gastroenterological Association were derived from this review.","journal-title":"Gastroenterology"},{"key":"55_CR4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0016-5085(76)80308-3","volume":"70","author":"DM Switz","year":"1976","unstructured":"Switz DM: What a gastroenterologist does all day. A survey of a state society\u2019s practice. Gastroenterology 1976, 70:1048\u20131050.","journal-title":"Gastroenterology"},{"key":"55_CR5","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(95)90738-6","volume":"109","author":"NJ Talley","year":"1995","unstructured":"Talley NJ, Gabriel SE, Harmsen WS, et al.: Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995, 109:1736\u20131741.","journal-title":"Gastroenterology"},{"key":"55_CR6","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/gut.30.8.1099","volume":"30","author":"R Nanda","year":"1989","unstructured":"Nanda R, James R, Smith H, et al.: Food intolerance and the irritable bowel syndrome. Gut 1989, 30:1099\u20131104.","journal-title":"Gut"},{"key":"55_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(94)91055-3","volume":"344","author":"CY Francis","year":"1994","unstructured":"Francis CY, Whorwell PJ: Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994, 344:39\u201340.","journal-title":"Lancet"},{"key":"55_CR8","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gut.28.11.1510","volume":"28","author":"A Prior","year":"1987","unstructured":"Prior A, Whorwell PJ: Double blind trial of ispaghula in irritable bowel syndrome. Gut 1987, 28:1510\u20131513.","journal-title":"Gut"},{"key":"55_CR9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0016-5085(88)90319-8","volume":"95","author":"KB Klein","year":"1988","unstructured":"Klein KB: Controlled treatment trials in the irritable bowel syndrome. Gastroenterology 1988, 95:232\u2013241. A classic paper highlighting the inadequacies of treatment trials, concluding that there was insufficient evidence of benefit from treatment trials on IBS at that time.","journal-title":"Gastroenterology"},{"key":"55_CR10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000199329","volume":"34","author":"W Kruis","year":"1986","unstructured":"Kruis W, Weinzierl M, Schussler P, et al.: Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with irritable bowel syndrome. Digestion 1986, 34:196\u2013201.","journal-title":"Digestion"},{"key":"55_CR11","first-page":"232","volume":"77","author":"C Tasman-Jones","year":"1973","unstructured":"Tasman-Jones C: Mebeverine in patients with the irritable colon syndrome: a double blind study. N Z Med J 1973, 77:232\u2013235.","journal-title":"N Z Med J"},{"key":"55_CR12","first-page":"285","volume":"21","author":"L Capurso","year":"1984","unstructured":"Capurso L, Koch M, Tarquini M, et al.: The irritable bowel syndrome: a cross over study of octilonium bromide, mebeverine and placebo. Clin Trials J 1984, 21:285\u2013291.","journal-title":"Clin Trials J"},{"key":"55_CR13","first-page":"2343","volume":"88","author":"J Berthelot","year":"1981","unstructured":"Berthelot J, Centonze M: Etude controllee en double aveugle duspatalin (mebeverine) contre placebo, dans le traitement du colon irritable. Gaz Med Fr 1981, 88:2343.","journal-title":"Gaz Med Fr"},{"key":"55_CR14","first-page":"394","volume":"38","author":"MJ Dew","year":"1995","unstructured":"Dew MJ, Evans BK, Rhodes J: Peppermint oil for the irritable bowel syndrome: a multicentre trial. Br J Clin Pract 1995, 38:394.","journal-title":"Br J Clin Pract"},{"key":"55_CR15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1742-1241.1986.tb07981.x","volume":"40","author":"P Nash","year":"1986","unstructured":"Nash P, Gould SR, Bernardo DE: Peppermint oil does not relieve the pain of irritable bowel syndrome. Br J Clin Pract 1986, 40:292\u2013293.","journal-title":"Br J Clin Pract"},{"key":"55_CR16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/bmj.2.6194.835","volume":"2","author":"WD Rees","year":"1979","unstructured":"Rees WD, Evans BK, Rhodes J: Treating irritable bowel syndrome with peppermint oil. Br Med J 1979, 2:835\u2013836.","journal-title":"Br Med J"},{"key":"55_CR17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0016-5085(79)90012-X","volume":"77","author":"G Piai","year":"1979","unstructured":"Piai G, Mazzacca G: Prifinium bromide in the treatment of the irritable colon syndrome. Gastroenterology 1979, 77:500\u2013502.","journal-title":"Gastroenterology"},{"key":"55_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/030006057900700311","volume":"7","author":"MG Moshal","year":"1979","unstructured":"Moshal MG, Herron M: A clinical trial of trimebutine (mebutin) in spastic colon. J Int Med Res 1979, 7:231\u2013234.","journal-title":"J Int Med Res"},{"key":"55_CR19","first-page":"377","volume":"73","author":"JF Fielding","year":"1980","unstructured":"Fielding JF: Double blind trial of trimebutine in the irritable bowel syndrome. Ir Med J 1980, 73:377\u2013379.","journal-title":"Ir Med J"},{"key":"55_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/gut.31.3.355","volume":"31","author":"G Dobrilla","year":"1990","unstructured":"Dobrilla G, Imbimbo BP, Piazzi L, et al.: Long term treatment of irritable bowel syndrome with cimetropium bromide: a double blind, placebo controlled clinical trial. Gut 1990, 31:355\u2013358.","journal-title":"Gut"},{"key":"55_CR21","first-page":"967","volume":"41","author":"G Piai","year":"1987","unstructured":"Piai G, Visconti M, Imbimbo B, et al.: Long term treatment of irritable bowel syndrome with cimetropium bromide, a new antimuscarinic compound. Curr Ther Res 1987, 41:967\u2013977.","journal-title":"Curr Ther Res"},{"key":"55_CR22","first-page":"1262","volume":"83","author":"V Centonze","year":"1988","unstructured":"Centonze V, Imbimbo BP, Campanozzi F, et al.: Oral cimetropium bromide, a new antimuscarinic drug, for long term treatment of irritable bowel syndrome. Am J Gastroenterol 1988, 83:1262\u20131266.","journal-title":"Am J Gastroenterol"},{"key":"55_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00004836-198106000-00009","volume":"3","author":"JG Page","year":"1981","unstructured":"Page JG, Dirnberger GM: Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride). J Clin Gastroenterol 1981, 3:153\u2013156.","journal-title":"J Clin Gastroenterol"},{"key":"55_CR24","first-page":"488","volume":"108","author":"E Schafer","year":"1990","unstructured":"Schafer E, Ewe K: Efficacy and toleration of Buscopan plus, Buscopan, paracetamol and placebo in ambulatory patients with IBS. Fortschr Med 1990, 108:488\u2013492.","journal-title":"Fortschr Med"},{"key":"55_CR25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2036.1994.tb00322.x","volume":"8","author":"T Poynard","year":"1994","unstructured":"Poynard T, Naveau S, Mory B, et al.: Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994, 8:499\u2013510. An important meta-analysis of treatment trials that demonstrated modest benefit from antispasmodics. However, there has been some criticism of the methodology used.","journal-title":"Aliment Pharmacol Ther"},{"key":"55_CR26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2036.2001.00937.x","volume":"15","author":"T Poynard","year":"2001","unstructured":"Poynard T, Regimbeau C, Benhamou Y: Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001, 15:355\u2013361. An update of the article by Poynard et al. [25], confirming the initial results.","journal-title":"Aliment Pharmacol Ther"},{"key":"55_CR27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01296258","volume":"29","author":"PA Cann","year":"1984","unstructured":"Cann PA, Read NW, Holdsworth CD, Barends D: Role of loperamide and placebo in management of irritable bowel syndrome. Dig Dis Sci 1984, 29:239\u20132347.","journal-title":"Dig Dis Sci"},{"key":"55_CR28","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/gut.32.9.1004","volume":"32","author":"AK Williams","year":"1991","unstructured":"Williams AK, Merrick MV, Eastwood MA: Idiopathic bile acid malabsorption\u2014a review of clinical presentation, diagnosis and response to treatment. Gut 1991, 32:1004\u20131006.","journal-title":"Gut"},{"key":"55_CR29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(90)90177-F","volume":"89","author":"FA Lederle","year":"1990","unstructured":"Lederle FA, Busch DL, Mattox KM, et al.: Cost effective treatment of constipation in the elderly: a randomised double-blind comparison of sorbitol and lactulose. Am J Med 1990, 89:597\u2013601.","journal-title":"Am J Med"},{"key":"55_CR30","first-page":"261","volume":"85","author":"RI Andorsky","year":"1990","unstructured":"Andorsky RI, Goldner F: Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a doubleblind, placebo controlled study. Am J Gastroenterol 1990, 85:261\u2013265.","journal-title":"Am J Gastroenterol"},{"key":"55_CR31","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1053\/gast.2000.20392","volume":"119","author":"GR Locke","year":"2000","unstructured":"Locke GR, Pemberton JH, Phillips SF: AGA technical review on constipation. Gastroenterology 2000, 119:1766\u20131778. An up-to-date discussion of constipation. American Gastroenterological Association guidelines on this subject were formulated from this review.","journal-title":"Gastroenterology"},{"key":"55_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004836-199102000-00012","volume":"13","author":"M Outryve Van","year":"1991","unstructured":"Van Outryve M, Milo R, Toussaint J, et al.: Prokinetic treatment of constipation predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol 1991, 13:49\u201357.","journal-title":"J Clin Gastroenterol"},{"key":"55_CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2036.1997.133311000.x","volume":"11","author":"K Schutze","year":"1997","unstructured":"Schutze K, Brandstatter G, Dragosics B, et al.: Double blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome. Aliment Pharmacol Ther 1997, 11:387\u2013394.","journal-title":"Aliment Pharmacol Ther"},{"issue":"suppl 2","key":"55_CR34","first-page":"II1","volume":"47","author":"J Jones","year":"2000","unstructured":"JonesJ, Boorman J, Cann P, et al.: British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000: 47(suppl 2):II1-II19. A review and United Kingdom consensus guidelines on issues related to IBS.","journal-title":"Gut"},{"key":"55_CR35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0033-3182(78)70930-8","volume":"19","author":"JD Heefner","year":"1978","unstructured":"Heefner JD, Wilder RM, Wilson JD: Irritable colon and depression. Psychosomatics 1978, 19:540\u2013547.","journal-title":"Psychosomatics"},{"key":"55_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01297051","volume":"32","author":"DS Greenbaum","year":"1987","unstructured":"Greenbaum DS, Mayle JE, Vanegeren LE, et al.: The effects of desipramine on IBS compared with atropine and placebo. Dig Dis Sci 1987, 32:257\u2013266.","journal-title":"Dig Dis Sci"},{"key":"55_CR37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/00365528209181108","volume":"17","author":"J Myren","year":"1982","unstructured":"Myren J, Groth H, Larssen S-E, et al.: The effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 1982, 17:871\u2013875.","journal-title":"Scand J Gastroenterol"},{"key":"55_CR38","first-page":"201","volume":"31","author":"BM Tripathi","year":"1989","unstructured":"Tripathi BM, Misra NP, Gupta AK: Evaluation of tricyclic compound (trimipramine) vis-\u00e0-vis placebo in irritable bowel syndrome (double blind randomised study). J Assoc Physicians India 1989, 31:201\u2013203.","journal-title":"J Assoc Physicians India"},{"key":"55_CR39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/00365521.1984.12005817","volume":"19","author":"J Myren","year":"1984","unstructured":"Myren J, Lovland B, Larssen S-E, et al.: A double blind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 1984, 19:835\u2013843.","journal-title":"Scand J Gastroenterol"},{"key":"55_CR40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02063948","volume":"40","author":"DA Gorard","year":"1995","unstructured":"Gorard DA, Libby GW, Farthing MJG: Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhoea-predominant irritable bowel syndrome. Dig Dis Sci 1995, 40:86\u201395.","journal-title":"Dig Dis Sci"},{"key":"55_CR41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.281.6251.1317","volume":"281","author":"JA Ritchie","year":"1980","unstructured":"Ritchie JA, Truelove SC: Comparison of various treatments for irritable bowel syndrome. Br Med J 1980, 281:1317\u20131319.","journal-title":"Br Med J"},{"key":"55_CR42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0447.1982.tb00912.x","volume":"66","author":"MJ Lancaster Smith","year":"1982","unstructured":"Lancaster Smith MJ, Prout BJ, Pinto T, et al.: Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand 1982, 66:33\u201341.","journal-title":"Acta Psychiatr Scand"},{"key":"55_CR43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11938-001-0058-7","volume":"4","author":"P Boyce","year":"2001","unstructured":"Boyce P: Psychologic therapies for irritable bowel syndrome. Curr Treat Opt Gastroenterol 2001, 4:323\u2013331.","journal-title":"Curr Treat Opt Gastroenterol"},{"issue":"suppl","key":"55_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1983.tb03707.x","volume":"67","author":"J Svedlund","year":"1983","unstructured":"Svedlund J: Psychotherapy in irritable bowel syndrome: a controlled outcome study. Acta Psychiatr Scand 1983, 67(suppl):1\u201386.","journal-title":"Acta Psychiatr Scand"},{"key":"55_CR45","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(84)92793-4","volume":"2","author":"PJ Whorwell","year":"1984","unstructured":"Whorwell PJ, Prior A, Faragher EB: Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome. Lancet 1984, 2:1232\u20131233.","journal-title":"Lancet"},{"key":"55_CR46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.2044-8260.1985.tb01340.x","volume":"24","author":"P Bennett","year":"1985","unstructured":"Bennett P, Wilkinson S: A comparison of psychological and medical treatment of the irritable bowel syndrome. Br J Clin Psychol 1985, 24:215\u2013216.","journal-title":"Br J Clin Psychol"},{"key":"55_CR47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0005-7894(89)80130-3","volume":"20","author":"PM Lynch","year":"1989","unstructured":"Lynch PM, Zamble E: A controlled behavioral treatment study of irritable bowel syndrome. Behavior Ther 1989, 20:509\u2013523.","journal-title":"Behavior Ther"},{"key":"55_CR48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0016-5085(91)90215-7","volume":"100","author":"E Guthrie","year":"1991","unstructured":"Guthrie E, Creed F, Dawson D, et al.: A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991, 100:450\u2013457.","journal-title":"Gastroenterology"},{"key":"55_CR49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000200738","volume":"50","author":"G Shaw","year":"1991","unstructured":"Shaw G, Srivastava ED, Sadlier M, et al.: Stress management for the irritable bowel syndrome: a controlled trial. Digestion 1991, 50:36\u201342.","journal-title":"Digestion"},{"key":"55_CR50","first-page":"33","volume-title":"Current Approaches Towards Confident Management of Irritable Bowel Syndrome","author":"N Rumsey","year":"1991","unstructured":"Rumsey N: Group stress management programmes vs pharmacological treatment in the treatment of irritable bowel syndrome. In Current Approaches Towards Confident Management of Irritable Bowel Syndrome. Edited by Heaton KW, Creed F, Goeting NLM. London: Lyme Regis Printing Co; 1991:33\u201339."},{"key":"55_CR51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0022-3999(91)90041-L","volume":"35","author":"RH Corney","year":"1991","unstructured":"Corney RH, Stanton R, Newell R, et al.: Behavioural psychotherapy in the treatment of irritable bowel syndrome. J Psychosom Res 1991, 35:461\u2013469.","journal-title":"J Psychosom Res"},{"key":"55_CR52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00999789","volume":"18","author":"EB Blanchard","year":"1993","unstructured":"Blanchard EB, Greene B, Scharff L, et al.: Relaxation training as a treatment for irritable bowel syndrome. Biofeedback Self Reg 1993, 18:125\u2013132.","journal-title":"Biofeedback Self Reg"},{"key":"55_CR53","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1037\/0022-006X.62.3.576","volume":"62","author":"B Greene","year":"1994","unstructured":"Greene B, Blanchard EB: Cognitive therapy for irritable bowel syndrome. J Consult Clin Psychol 1994, 62:576\u2013582.","journal-title":"J Consult Clin Psychol"},{"key":"55_CR54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/gut.39.1.130","volume":"39","author":"U Bengtsson","year":"1996","unstructured":"Bengtsson U, Nilsson-Balknas U, Hanson LA, et al.: Double blind placebo controlled food reactions do not correlate to IgE allergy in the diagnosis of staple food related gastrointestinal symptoms. Gut 1996, 39:130\u2013135.","journal-title":"Gut"},{"key":"55_CR55","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00042737-199610000-00015","volume":"8","author":"CJ Bohmer","year":"1996","unstructured":"Bohmer CJ, Tuyman HA: The clinical relevance of lactose malabsorption in the irritable bowel syndrome. Eur J Gastroenterol Hepatol 1996, 8:1013\u20131016.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-001-0055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-001-0055-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-001-0055-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:16:45Z","timestamp":1707938205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-001-0055-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1007\/s11938-001-0055-x","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}